JP6170234B2 - レベチラセタムを含む急速に分散する剤形 - Google Patents

レベチラセタムを含む急速に分散する剤形 Download PDF

Info

Publication number
JP6170234B2
JP6170234B2 JP2016502945A JP2016502945A JP6170234B2 JP 6170234 B2 JP6170234 B2 JP 6170234B2 JP 2016502945 A JP2016502945 A JP 2016502945A JP 2016502945 A JP2016502945 A JP 2016502945A JP 6170234 B2 JP6170234 B2 JP 6170234B2
Authority
JP
Japan
Prior art keywords
dosage form
matrix
lev
less
bound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016502945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016514680A (ja
JP2016514680A5 (enExample
Inventor
ジュール・ジェイコブ
ノーマン・コイル
トーマス・ジー・ウェスト
ドナルド・シー・モンクハウス
ヘンリー・エル・サープリナント
ネミチャンド・ビー・ジェイン
Original Assignee
アプレシア・ファーマスーティカルズ・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アプレシア・ファーマスーティカルズ・カンパニー filed Critical アプレシア・ファーマスーティカルズ・カンパニー
Publication of JP2016514680A publication Critical patent/JP2016514680A/ja
Publication of JP2016514680A5 publication Critical patent/JP2016514680A5/ja
Application granted granted Critical
Publication of JP6170234B2 publication Critical patent/JP6170234B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016502945A 2013-03-15 2014-03-14 レベチラセタムを含む急速に分散する剤形 Active JP6170234B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361791444P 2013-03-15 2013-03-15
US61/791,444 2013-03-15
PCT/US2014/028954 WO2014144512A1 (en) 2013-03-15 2014-03-14 Rapid disperse dosage form containing levetiracetam

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016231964A Division JP6640069B2 (ja) 2013-03-15 2016-11-30 レベチラセタムを含む急速に分散する剤形

Publications (3)

Publication Number Publication Date
JP2016514680A JP2016514680A (ja) 2016-05-23
JP2016514680A5 JP2016514680A5 (enExample) 2016-09-15
JP6170234B2 true JP6170234B2 (ja) 2017-07-26

Family

ID=51537722

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016502945A Active JP6170234B2 (ja) 2013-03-15 2014-03-14 レベチラセタムを含む急速に分散する剤形
JP2016231964A Active JP6640069B2 (ja) 2013-03-15 2016-11-30 レベチラセタムを含む急速に分散する剤形
JP2018116552A Active JP6788633B2 (ja) 2013-03-15 2018-06-20 レベチラセタムを含む急速に分散する剤形

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016231964A Active JP6640069B2 (ja) 2013-03-15 2016-11-30 レベチラセタムを含む急速に分散する剤形
JP2018116552A Active JP6788633B2 (ja) 2013-03-15 2018-06-20 レベチラセタムを含む急速に分散する剤形

Country Status (10)

Country Link
US (2) US20220211668A1 (enExample)
EP (2) EP3431141B1 (enExample)
JP (3) JP6170234B2 (enExample)
CN (2) CN109908355B (enExample)
AU (2) AU2014228990B2 (enExample)
CA (1) CA2906029C (enExample)
ES (2) ES2688880T3 (enExample)
HK (1) HK1216513A1 (enExample)
MX (1) MX365513B (enExample)
WO (1) WO2014144512A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
AU2014228990B2 (en) * 2013-03-15 2017-02-02 Aprecia Pharmaceuticals LLC Rapid disperse dosage form containing levetiracetam
US10653622B1 (en) 2015-04-13 2020-05-19 Pharmacoustics Technologies LLC Individualized solid dosage products and a system and method for the globally integrated pharmaceutical manufacturing and its monitoring thereof
EP4512394A3 (en) 2015-06-03 2025-10-22 Triastek, Inc. Dosage forms and use thereof
KR20190050807A (ko) 2016-09-09 2019-05-13 메르크 파텐트 게엠베하 고체 약학적 투여 형태의 제조 방법
CA3051614A1 (en) 2017-01-26 2018-08-02 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
US11602502B2 (en) 2017-02-24 2023-03-14 Hewlett-Packard Development Company, L.P. Three-dimensional (3D) printing a pharmaceutical tablet
DK3592337T3 (da) 2017-03-08 2023-09-18 Cinrx Pharma Llc Farmaceutiske formuleringer af phloroglucinol og trimethylphloroglucinol
CA3058374C (en) 2017-03-31 2022-03-08 Nippon Steel Chemical & Material Co., Ltd. Carbon material for use as catalyst carrier of polymer electrolyte fuel cell and method of producing the same
JP6653931B2 (ja) * 2017-06-16 2020-02-26 丸石製薬株式会社 レベチラセタム含有ゲル経口医薬組成物
US11571391B2 (en) 2018-01-09 2023-02-07 Triastek, Inc. Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant
JP7264711B2 (ja) * 2019-04-26 2023-04-25 東和薬品株式会社 レベチラセタム含有医薬組成物の製造方法
AU2020282027B2 (en) 2019-05-31 2025-11-13 Dihesys Digital Health Systems Gmbh Pharmaceutical dosage forms and method for their production
TWI734309B (zh) * 2019-12-19 2021-07-21 水星生醫股份有限公司 滲透性噴塗製作藥錠裝置
WO2021174192A1 (en) 2020-02-27 2021-09-02 Henkel IP & Holding GmbH Conditioning composition
CN111840243B (zh) * 2020-07-30 2021-11-30 中国人民解放军军事科学院军事医学研究院 一种左乙拉西坦3d打印制剂及其制备方法
CN113599362A (zh) * 2021-01-15 2021-11-05 中国人民解放军军事科学院军事医学研究院 一种3d打印制剂及其制备方法和其应用
KR20250008880A (ko) 2022-04-13 2025-01-16 아프레시아 파마슈티칼즈 엘엘씨 전방향 자기 운동 장치를 이용한 적층 제조를 위한 시스템 및 방법
GB2643926A (en) * 2024-09-09 2026-03-11 Novumgen Ltd An orodispersible tablet of levetiracetam and its process of preparation

Family Cites Families (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
GB8412357D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
CH660750A5 (en) 1984-11-06 1987-06-15 Thomae Gmbh Dr K Physiologically acceptable inks for printing mouldings having a porous surface by inkjet writing means
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5121329A (en) 1989-10-30 1992-06-09 Stratasys, Inc. Apparatus and method for creating three-dimensional objects
US5204055A (en) 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
US5387380A (en) 1989-12-08 1995-02-07 Massachusetts Institute Of Technology Three-dimensional printing techniques
US5127037A (en) 1990-08-15 1992-06-30 Bynum David K Apparatus for forming a three-dimensional reproduction of an object from laminations
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
US5252264A (en) 1991-11-08 1993-10-12 Dtm Corporation Apparatus and method for producing parts with multi-directional powder delivery
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5641561A (en) 1992-08-17 1997-06-24 Weyerhaeuser Company Particle binding to fibers
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
US5490882A (en) 1992-11-30 1996-02-13 Massachusetts Institute Of Technology Process for removing loose powder particles from interior passages of a body
US6146567A (en) 1993-02-18 2000-11-14 Massachusetts Institute Of Technology Three dimensional printing methods
WO1995001782A2 (en) 1993-07-09 1995-01-19 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US6280771B1 (en) 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US5518680A (en) 1993-10-18 1996-05-21 Massachusetts Institute Of Technology Tissue regeneration matrices by solid free form fabrication techniques
US5879489A (en) 1993-11-24 1999-03-09 Burns; Marshall Method and apparatus for automatic fabrication of three-dimensional objects
WO1995034468A1 (en) 1994-06-14 1995-12-21 Soligen, Inc. Powder handling apparatus for additive fabrication equipment
JPH0892105A (ja) 1994-09-26 1996-04-09 Ota Seiyaku Kk 速溶性の経口投与用アルギン酸ナトリウム固形製剤
US5717599A (en) 1994-10-19 1998-02-10 Bpm Technology, Inc. Apparatus and method for dispensing build material to make a three-dimensional article
US5738875A (en) 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US6270335B2 (en) 1995-09-27 2001-08-07 3D Systems, Inc. Selective deposition modeling method and apparatus for forming three-dimensional objects and supports
US5660621A (en) 1995-12-29 1997-08-26 Massachusetts Institute Of Technology Binder composition for use in three dimensional printing
US6596224B1 (en) 1996-05-24 2003-07-22 Massachusetts Institute Of Technology Jetting layers of powder and the formation of fine powder beds thereby
US5902441A (en) 1996-09-04 1999-05-11 Z Corporation Method of three dimensional printing
BR9705156A (pt) 1996-10-25 2000-01-04 Massachusetts Inst Technology Processo e sistema de fabricar um componente que consiste em partes constituìdas de diferentes materiais
US6007318A (en) 1996-12-20 1999-12-28 Z Corporation Method and apparatus for prototyping a three-dimensional object
US7037382B2 (en) 1996-12-20 2006-05-02 Z Corporation Three-dimensional printer
US6989115B2 (en) 1996-12-20 2006-01-24 Z Corporation Method and apparatus for prototyping a three-dimensional object
WO1998036738A1 (en) * 1997-02-20 1998-08-27 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
US6213168B1 (en) 1997-03-31 2001-04-10 Therics, Inc. Apparatus and method for dispensing of powders
CA2288201A1 (en) 1997-03-31 1998-10-08 Therics, Inc. Method for dispensing of powders
US5940674A (en) 1997-04-09 1999-08-17 Massachusetts Institute Of Technology Three-dimensional product manufacture using masks
JP3615376B2 (ja) 1997-12-15 2005-02-02 富士写真フイルム株式会社 被印刷体の色補正方法およびその装置
US6322728B1 (en) 1998-07-10 2001-11-27 Jeneric/Pentron, Inc. Mass production of dental restorations by solid free-form fabrication methods
US6821462B2 (en) 1998-07-10 2004-11-23 Jeneric/Pentron, Inc. Mass production of shells and models for dental restorations produced by solid free-form fabrication methods
US6808659B2 (en) 1998-07-10 2004-10-26 Jeneric/Pentron Incorporated Solid free-form fabrication methods for the production of dental restorations
US6363606B1 (en) 1998-10-16 2002-04-02 Agere Systems Guardian Corp. Process for forming integrated structures using three dimensional printing techniques
EP1124688B1 (en) 1998-10-29 2004-04-07 Z Corporation Three dimensional printing material system and method
US6547994B1 (en) 1998-11-13 2003-04-15 Therics, Inc. Rapid prototyping and manufacturing process
US6165406A (en) 1999-05-27 2000-12-26 Nanotek Instruments, Inc. 3-D color model making apparatus and process
DE19940944B4 (de) 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen
US6658314B1 (en) 1999-10-06 2003-12-02 Objet Geometries Ltd. System and method for three dimensional model printing
DE19948591A1 (de) 1999-10-08 2001-04-19 Generis Gmbh Rapid-Prototyping - Verfahren und - Vorrichtung
US20030173695A1 (en) * 1999-11-12 2003-09-18 Therics, Inc. Rapid prototyping and manufacturing process
US20050104241A1 (en) 2000-01-18 2005-05-19 Objet Geometried Ltd. Apparatus and method for three dimensional model printing
US6850334B1 (en) 2000-01-18 2005-02-01 Objet Geometries Ltd System and method for three dimensional model printing
US6360656B2 (en) 2000-02-28 2002-03-26 Minolta Co., Ltd. Apparatus for and method of printing on three-dimensional object
US7300619B2 (en) 2000-03-13 2007-11-27 Objet Geometries Ltd. Compositions and methods for use in three dimensional model printing
US20030207959A1 (en) 2000-03-13 2003-11-06 Eduardo Napadensky Compositions and methods for use in three dimensional model printing
US6772026B2 (en) 2000-04-05 2004-08-03 Therics, Inc. System and method for rapidly customizing design, manufacture and/or selection of biomedical devices
HK1049299B (en) * 2000-04-14 2013-06-07 3D Systems, Inc. Compositions and method for three-dimensional printing of solid objects
US20010050031A1 (en) * 2000-04-14 2001-12-13 Z Corporation Compositions for three-dimensional printing of solid objects
AU2001263506A1 (en) 2000-05-18 2001-11-26 Massachusetts Institute Of Technology Encapsulating a toxic core within a non-toxic region in an oral dosage form
JP3546846B2 (ja) 2001-01-22 2004-07-28 セイコーエプソン株式会社 印刷装置
GB0103754D0 (en) 2001-02-15 2001-04-04 Vantico Ltd Three-dimensional structured printing
GB2376920A (en) 2001-06-27 2002-12-31 Inca Digital Printers Ltd Inkjet printing on a three-dimensional object including relative movement of a printhead and the object during printing about a rotational axis
US20030041962A1 (en) 2001-09-05 2003-03-06 John R. Johnson Digitally printed products and process
CA2464478C (en) * 2001-10-29 2012-03-20 Therics, Inc. A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
WO2003037632A1 (en) 2001-10-29 2003-05-08 Therics, Inc. A method and system for controlling the temperature of a dispensed liquid
US7300668B2 (en) 2001-10-29 2007-11-27 Massachusetts Institute Of Technology System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
US7411008B2 (en) 2001-11-07 2008-08-12 Novartis Ag Ink formulations and uses thereof
GB0127252D0 (en) 2001-11-13 2002-01-02 Vantico Ag Production of composite articles composed of thin layers
US20030151167A1 (en) 2002-01-03 2003-08-14 Kritchman Eliahu M. Device, system and method for accurate printing of three dimensional objects
EP1488811A1 (en) 2002-03-06 2004-12-22 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
AU2003232078A1 (en) 2002-05-06 2003-11-17 Massachusetts Institute Of Technology Diffusion-controlled dosage form and method of fabrication including three dimensional printing
FI111922B (fi) 2002-05-31 2003-10-15 Perlos Oyj Menetelmä kolmiulotteisten pintojen kuviointiin
CZ297082B6 (cs) 2002-06-03 2006-09-13 Ing. Ilja Krejcí-Engineering Soucástky s trojrozmernou strukturou pripravené tlustovrstvou technologií a zpusob jejich výroby
US7027887B2 (en) 2002-07-03 2006-04-11 Theries, Llc Apparatus, systems and methods for use in three-dimensional printing
GB0219516D0 (en) * 2002-08-21 2002-10-02 Phoqus Ltd Fast dissolving and taste masked oral dosage form comprising sildenafil
US20040038009A1 (en) * 2002-08-21 2004-02-26 Leyden Richard Noel Water-based material systems and methods for 3D printing
EP1539500A4 (en) 2002-09-12 2006-03-29 Objet Geometries Ltd DEVICE, SYSTEM AND METHOD FOR CALIBRATING IN THREE-DIMENSIONAL MODEL PRESSURE
DE10261985A1 (de) 2002-09-21 2004-04-08 Koenig & Bauer Ag Vorrichtung zum Einstellen des Anpressdrucks einer verstellbar gelagerten Walze
US7087109B2 (en) 2002-09-25 2006-08-08 Z Corporation Three dimensional printing material system and method
US20040112523A1 (en) 2002-10-15 2004-06-17 Crom Elden Wendell Three dimensional printing from two dimensional printing devices
US7725209B2 (en) 2002-11-12 2010-05-25 Objet Geometries Ltd Three-dimensional object printing
WO2004043200A1 (en) 2002-11-13 2004-05-27 Miic America, Inc. A system and process for creating custom fit artificial fingernails using a non-contact optical measuring device
AU2003286397A1 (en) 2002-12-03 2004-06-23 Objet Geometries Ltd. Process of and apparatus for three-dimensional printing
US7589868B2 (en) 2002-12-11 2009-09-15 Agfa Graphics Nv Method and apparatus for creating 3D-prints and a 3-D printing system
AU2003900180A0 (en) 2003-01-16 2003-01-30 Silverbrook Research Pty Ltd Method and apparatus (dam001)
WO2004078069A2 (en) 2003-03-05 2004-09-16 Therics, Inc. Process for manufacturing biomedical articles by infiltrating biocompatible metal alloys in porous matrices
CN1819819B (zh) 2003-05-07 2011-03-09 株式会社三养社 用于制备速熔片的高度可塑性颗粒
WO2004106041A2 (en) 2003-05-23 2004-12-09 Z Corporation Apparatus and methods for 3d printing
GB0312909D0 (en) 2003-06-05 2003-07-09 Univ Liverpool Apparatus for manufacturing three dimensional items
US7445441B2 (en) 2003-07-14 2008-11-04 Therics, Llc Three-dimensional printing apparatus and methods of manufacture including sterilization or disinfection, for example, using ultraviolet light
FR2858556B1 (fr) 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
WO2005023524A2 (en) 2003-08-29 2005-03-17 Z Corporation Absorbent fillers for three-dimensional printing
FR2859128B1 (fr) 2003-08-29 2006-03-10 Centre Nat Rech Scient Procede et dispositif de fabrication d'un composant multimateriaux tridimensionnel par impression du type jet d'encre
US7220380B2 (en) 2003-10-14 2007-05-22 Hewlett-Packard Development Company, L.P. System and method for fabricating a three-dimensional metal object using solid free-form fabrication
US7365129B2 (en) 2003-10-14 2008-04-29 Hewlett-Packard Development Company, L.P. Polymer systems with reactive and fusible properties for solid freeform fabrication
EP1756646A2 (en) 2004-02-06 2007-02-28 Nagayama IP Holdings llc Complex pointillistic multicolor printing
US7407250B2 (en) 2004-02-18 2008-08-05 Pixal Wizard International, Inc Apparatus, system, and method for multi-dimensional registration printing
US7383768B2 (en) 2004-05-05 2008-06-10 Awi Licensing Company Rapid prototyping and filling commercial pipeline
JPWO2005116152A1 (ja) 2004-05-27 2008-04-03 株式会社ピーアイ技術研究所 印刷用ブロック共重合ポリイミドインク組成物
KR100606457B1 (ko) 2004-11-11 2006-11-23 한국기계연구원 3차원 프린팅 조형시스템
EP1827391B1 (en) * 2004-11-26 2015-09-23 Aprecia Pharmaceuticals Co. Three dimensionally printed dosage forms
ES2294979T1 (es) * 2005-01-27 2008-04-16 Alembic Limited Formulacion de levetiracetam de liberacion prolongada.
WO2006102750A1 (en) 2005-03-30 2006-10-05 Genpharm Inc. Combined-step process for pharmaceutical compositions
HRP20141185T1 (hr) 2005-07-26 2015-01-30 Ucb Pharma Sa Farmaceutski pripravci koji sadrže levetiracetam i proces za njihovu pripremu
EP1759791A1 (en) 2005-09-05 2007-03-07 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Apparatus and method for building a three-dimensional article
RU2417890C2 (ru) 2005-09-20 2011-05-10 Птс Софтвэар Бв Устройство формирования трехмерного изделия и способ формирования трехмерного изделия
JP4227642B2 (ja) 2005-12-28 2009-02-18 キヤノン株式会社 立体物の製造方法、及び立体物の製造装置
US7978363B2 (en) 2006-02-15 2011-07-12 Seiko Epson Corporation Printing apparatus and printing method
US8784886B2 (en) * 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
JP5535616B2 (ja) * 2006-03-31 2014-07-02 ルビコン リサーチ プライベート リミテッド 口腔内崩壊錠剤のための直接圧縮性複合材
US7971991B2 (en) 2006-05-26 2011-07-05 Z Corporation Apparatus and methods for handling materials in a 3-D printer
MX2009002166A (es) * 2006-08-31 2009-03-12 Eurand Inc Sistema de distribucion de farmacos, que comprenden soluciones solidas de farmacos debilmente basicos.
JP2008114493A (ja) 2006-11-06 2008-05-22 Mimaki Engineering Co Ltd 三次元プリンタ
US7905951B2 (en) 2006-12-08 2011-03-15 Z Corporation Three dimensional printing material system and method using peroxide cure
SI2319804T1 (sl) * 2006-12-14 2015-01-30 Novartis Ag Fosfatni adsorbent na osnovi Ĺľelezo(III)-ogljikovega hidrata
WO2008086033A1 (en) 2007-01-10 2008-07-17 Z Corporation Three-dimensional printing material system with improved color, article performance, and ease of use
JP2008183778A (ja) 2007-01-29 2008-08-14 Seiko Epson Corp ２次元コード印刷方法、そのプログラム及びインクジェットプリンタ
US7968626B2 (en) 2007-02-22 2011-06-28 Z Corporation Three dimensional printing material system and method using plasticizer-assisted sintering
US7655163B2 (en) 2007-05-09 2010-02-02 Sanwa Screen Co., Ltd. Manufacturing method of film insert molded article
ATE542525T1 (de) 2007-10-16 2012-02-15 Pharmathen Sa Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung
MX2010005861A (es) * 2007-11-30 2010-06-11 Pfizer Ltd Agonistas novedosos de los receptores de glucocorticoides.
CN105496978A (zh) * 2007-12-21 2016-04-20 阿代尔制药股份有限公司 替马西泮的口腔崩解片组合物
WO2009106824A2 (en) 2008-02-25 2009-09-03 Cipla Limited Pharmaceutical formulations
CN101269052B (zh) * 2008-03-27 2010-06-23 东华大学 口腔速溶速效药膜及其三维打印制备方法
WO2009124357A1 (en) * 2008-04-10 2009-10-15 Malvin Leonard Eutick Fast dissolving oral formulations for critical drugs
TWI539953B (zh) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
CN101439584B (zh) * 2008-08-29 2011-03-23 东华大学 一种微乳液体黏结剂三维打印系统可打印性能的测定方法
EP2482822B1 (en) * 2009-10-01 2018-08-01 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
US20110105441A1 (en) 2009-10-30 2011-05-05 Fmc Corporation Stable Orally Disintegrating Tablets Having Low Superdisintegrant
CN102085194B (zh) * 2009-12-08 2013-12-25 北京以岭生物工程技术有限公司 左乙拉西坦口腔崩解片及其制备方法
WO2011136751A2 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic Water soluble pharmaceutical composition
US20110318390A1 (en) * 2010-06-28 2011-12-29 Fuisz Richard C Bioactive Dose Having a Rapid Release Coating or Rapid Release Layer Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive
CN102093646B (zh) * 2010-10-29 2012-07-18 华南理工大学 一种用于三维打印快速成型的材料及其制备方法
US8426461B2 (en) * 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
US9339489B2 (en) * 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
CA2906107C (en) 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of oxcarbazepine
WO2014144661A1 (en) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
AU2014228990B2 (en) * 2013-03-15 2017-02-02 Aprecia Pharmaceuticals LLC Rapid disperse dosage form containing levetiracetam

Also Published As

Publication number Publication date
AU2014228990B2 (en) 2017-02-02
CN105188849B (zh) 2019-01-15
JP2016514680A (ja) 2016-05-23
CN109908355A (zh) 2019-06-21
EP2968994A4 (en) 2016-03-16
AU2017202752B2 (en) 2018-07-26
JP6788633B2 (ja) 2020-11-25
JP2018162276A (ja) 2018-10-18
AU2014228990A1 (en) 2015-10-08
ES2908292T3 (es) 2022-04-28
MX2015012134A (es) 2016-02-03
CN105188849A (zh) 2015-12-23
EP2968994B1 (en) 2018-08-15
CA2906029C (en) 2017-09-05
WO2014144512A4 (en) 2014-11-13
HK1216513A1 (zh) 2016-11-18
CN109908355B (zh) 2022-11-15
HK1214787A1 (en) 2016-08-05
US12396979B2 (en) 2025-08-26
US20220211668A1 (en) 2022-07-07
AU2017202752A1 (en) 2017-05-18
CA2906029A1 (en) 2014-09-18
US20230069979A1 (en) 2023-03-09
ES2688880T3 (es) 2018-11-07
EP3431141A1 (en) 2019-01-23
JP6640069B2 (ja) 2020-02-05
MX365513B (es) 2019-06-06
WO2014144512A1 (en) 2014-09-18
EP3431141B1 (en) 2021-12-08
EP2968994A1 (en) 2016-01-20
JP2017071626A (ja) 2017-04-13

Similar Documents

Publication Publication Date Title
US12396979B2 (en) Rapid disperse dosage form
US11160786B2 (en) Rapid disperse dosage form
JP6463333B2 (ja) オキシカルバゼピンの急速分散性の剤形
JP6466399B2 (ja) トピラマートの急速分散性の剤形
ES2667944T3 (es) Gránulos y comprimidos orodispersables que contienen oxicodona
HK40009940B (en) Rapid disperse dosage form containing levetiracetam
HK40009940A (en) Rapid disperse dosage form containing levetiracetam
HK1214787B (en) Rapid disperse dosage form containing levetiracetam
HK1214173B (en) Rapidly dispersible dosage form of oxcarbazepine

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20151112

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A525

Effective date: 20151028

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20151112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160729

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160729

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20160729

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20160824

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170523

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170602

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170620

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170629

R150 Certificate of patent or registration of utility model

Ref document number: 6170234

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250